Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report published on Sunday. The firm issued a sell rating on the stock. Bio-Path Stock Performance Shares of Bio-Path stock opened at $0.77 on Friday. Bio-Path has a twelve month low of $0.61 and a twelve month high of $12.37. The business […]

Leave a Reply

Your email address will not be published.

Previous post Profire Energy (NASDAQ:PFIE) Now Covered by StockNews.com
Next post Inuvo (NYSE:INUV) Coverage Initiated by Analysts at StockNews.com